Breaking News

ICON, Intel Enter Pharma Analytics Platform Pact

ICON to offer the Intel Pharma Analytics Platform for use in clinical trials

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

ICON plc has entered an agreement with Intel Corp. to enable ICON to offer the Intel Pharma Analytics Platform for use in clinical trials. The Intel platform is an edge-to-cloud artificial intelligence (AI) solution that enables remote monitoring and continuous capture of clinical data from study subjects using sensors and wearable devices and can apply machine learning techniques to objectively measure symptoms and quantify the impact of therapies. Jointly configured by ICON and building on ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters